News for hackers. Stuff that matters.

A comment on Stanford Dropout Says Blood Startup Won't Be Another Theranos. Parent comment

Re:Stanford Dropout Says Blood Startup Won't Be Another Ther... by ttandon on Monday August 28, 2017 @05:13PM (#15120120)
CTCs are a very early application in our tech and one that we're excited to continue working on. We have some strong sample share relationships with Stanford and sensitivity/stage/specificity testing is in its early stages right now. Will publish on the data page when more information
[ Parent | on HN ]
Re:Stanford Dropout Says Blood Startup Won't Be Another Ther... by Balgair on Tuesday August 29, 2017 @02:37PM (#15126569)
Look at CU-Anschutz as well, CCTSI is very active in CTCs.
[ Parent | on HN ]